Shareholder of UCB (NYSE: UCB) plans sale of 25,000 shares

Rhea-AI Filing Summary

A shareholder in UCB has filed notice to sell 25,000 shares of common stock, with an aggregate market value of 865,500.00. The planned sale is through The Charles Schwab Corporation on the NYSE, with an approximate sale date of 02/17/2026.

These shares were acquired as compensation in transactions between 09/14/2015 and 11/15/2024, directly from the issuer. The filing lists total shares of this class outstanding as 121,556,906, providing context for the size of the planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	25000	865500.00	121556906	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	09/14/2015	COMPENSATION ACQUIRED BETWEEN: 9/14/15 - 11/15/24	ISSUER			25000	09/14/2015	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UCB's latest Form 144 filing disclose?

The filing shows a shareholder plans to sell 25,000 common shares of UCB, valued at 865,500.00. The sale will be executed through The Charles Schwab Corporation on the NYSE, providing advance notice under Rule 144.

How many UCB shares are being sold and what is their value?

The notice covers 25,000 common shares of UCB with an aggregate market value of 865,500.00. This figure reflects the planned sale amount reported in the Form 144, not the total ownership position of the shareholder.

When is the planned sale date for the UCB shares in this Form 144?

The planned sale date is approximately 02/17/2026. This date indicates when the shareholder expects to begin selling the 25,000 common shares on the NYSE through The Charles Schwab Corporation as broker.

How were the UCB shares in the Form 144 originally acquired?

The 25,000 common shares were acquired as compensation between 09/14/2015 and 11/15/2024. The filing states they were obtained from the issuer, reflecting stock-based compensation rather than open-market purchases.

How large is the planned UCB share sale relative to shares outstanding?

The class has 121,556,906 shares outstanding, while the filing covers 25,000 shares. This provides context showing the planned sale represents only a small fraction of the total shares outstanding for that class.

Which broker and exchange are involved in the UCB Form 144 sale?

The sale is designated to occur through The Charles Schwab Corporation as broker on the NYSE. These details indicate the intended trading venue and intermediary handling the planned sale of the 25,000 UCB common shares.